Antioxidants Abrogate Alpha-Tocopherylquinone-Mediated Down-Regulation of the Androgen Receptor in

Alexandra M Fajardo1, Debra A MacKenzie1, Sarah L Olguin1

  • 1Department of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, New Mexico, United States of America.

Plos One
|March 18, 2016
PubMed

Insights

Tocopherylquinone (TQ), an alpha-tocopherol oxidation product, potently inhibits prostate cancer cell growth and androgenic activity by down-regulating androgen receptors. Alpha-tocopherol (AT) showed no such effects, highlighting TQ's distinct therapeutic potential.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Alpha-tocopherol (AT) is a form of vitamin E with known biological functions.
  • Tocopherylquinone (TQ) is an oxidation product of AT with distinct properties.
  • Prostate cancer growth is often driven by androgen receptor (AR) signaling.

Purpose of the Study:

  • To compare the effects of AT and TQ on prostate cancer cell growth and androgenic activity.
  • To investigate the anti-androgenic mechanisms of TQ.
  • To determine if TQ's effects are distinct from AT.

Main Methods:

  • Cell culture of androgen-responsive (LAPC4, LNCaP) and androgen-independent (DU145) prostate cancer lines.
  • Reporter assays to measure androgen-induced activation.
  • Prostate-specific antigen (PSA) release assays.
  • Multifunctional Androgen Receptor Screening assay.
  • Quantitative gene expression analysis.
  • Western blotting for AR protein levels.
  • Antioxidant co-treatment experiments.

Main Results:

  • TQ significantly inhibited growth in androgen-responsive prostate cancer cells, but not androgen-independent cells.
  • TQ demonstrated potent anti-androgenic activity, inhibiting AR activation and PSA release.
  • TQ decreased expression of androgen-responsive genes (TM4SF1, KLK2, PSA) over 5-fold.
  • TQ down-regulated androgen receptor protein levels, an effect not seen with AT.
  • Antioxidants abrogated TQ-induced AR protein down-regulation.
  • AT did not affect androgenic endpoints or gene expression.

Conclusions:

  • Tocopherylquinone (TQ) exhibits distinct biological actions compared to alpha-tocopherol (AT).
  • TQ is a potent inhibitor of cell growth and androgenic activity in androgen-responsive prostate cancer.
  • TQ's anti-androgenic effects are mediated by the down-regulation of androgen receptor protein.

Related Concept Videos

Radical Autoxidation01:20

Radical Autoxidation

The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...
3.4K
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
1.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
104
Oxidation of Phenols to Quinones01:17

Oxidation of Phenols to Quinones

In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
5.2K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
6.2K